Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2005
03/10/2005US20050054735 6-Methoxy-2-naphthylacetic acid prodrugs
03/10/2005US20050054734 obesity, hypotensive agents, pretreatment for diabetes, metabolism syndrome ; administering dopaminergic agents and agents which reduces noradrenergic activity
03/10/2005US20050054732 Preventives or remidies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
03/10/2005US20050054731 Includes a biguanide hypoglycemic agent, a lipid lowering agent, a blood pressure lowering agent and, preferably, an anti-platelet agent
03/10/2005US20050054730 Dietetics; use in treatment of obesity, appetite disorder, metabolic disorder, cellulite, Type II diabetes, insulin resistance, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, artherogenesis, an inflammatory disorder or condition, Alzheimers disease, Crohn's disease
03/10/2005US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases
03/10/2005US20050054728 Oral and rectal drug delivery of a mixture of 4-aminophenylacetic acid and 5-aminosalicylic acid; antiinflammatory agents for gastrointestinal tract; antiulcer agents
03/10/2005US20050054727 For treating or delaying progression or onset of obesity, hypercholesterolemia, atherosclerosis, depression, osteoporosis, hypothyroidism, non-toxic goiter, reduced bone mass, density or growth, eating disorders, cardiac arrhythmia
03/10/2005US20050054726 Vaccine
03/10/2005US20050054725 Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulators
03/10/2005US20050054723 Administration to the individual of a prostaglandin analogue selective for the EP2 prostanoid receptor in combination with an alpha-adrenergic agonist
03/10/2005US20050054722 With halogenated furanones and related 3-haloalkenones; for inhibition of activities and actions of microorganisms, particularly bacteria; for treating bacterial infections, reducing biofilm formation
03/10/2005US20050054720 Saururus cernuus compounds that inhibit cellular responses to hypoxia
03/10/2005US20050054719 Dimeric compounds and their use as anti-viral agents
03/10/2005US20050054718 4S, 5R, 6R)-5-Acetylamino-4-azido-6-[(S)-4-nitrophenoxycarbonyloxy)-(2-oxo-[1,3]dioxolan-4R-yl)methyl]- 5,6-dihydro-4H-pyran2-carboxylic acid methylester; modified at the carboxyl or hydroxyl or amino functions; orthomyxovirus and paramyxovirus infections; a long lung residency time and high potency
03/10/2005US20050054717 Coumarin derivative
03/10/2005US20050054716 such as 7-O-methylthiomethylpaclitaxel having improved solubility, stability and oxidation resistance, for use as antitumor or anticarcinogenic agents
03/10/2005US20050054715 Vinyl phenyl derivatives as glk activators
03/10/2005US20050054714 Nitric oxide releasing drugs for Alzheimer's disease
03/10/2005US20050054713 3-Substituted oxindole beta3 agonists
03/10/2005US20050054711 with a substituted benzene ring; agonists of the progesterone receptorinducing contraception treating progesterone-related carcinomas and adenocarcinomas
03/10/2005US20050054710 Inhibits effect on various receptor tyrosine kinases and CDK (cyclin dependent kinases) complexes and on the proliferation of endothelial cells and various tumor cells
03/10/2005US20050054708 Combinations of drugs for the treatment of neoplasms
03/10/2005US20050054707 use treating Human Immunodeficiency Virus (HIV) , or genetically related retroviral, infection or a resulting acquired immunodeficiency syndrome (AIDS); reverse transcriptase inhibitors
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054704 Derivatives of [6,7-dihydro-5H- Imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
03/10/2005US20050054702 applying to surfaces synergystic mixtures of antiallergens comprising acyclic tertiary amines, sodium carbonate, erythorbic acid and hydantoins; miticides; dermatophagoides
03/10/2005US20050054701 Heterocyclic inhibitors of MEK and methods of use thereof
03/10/2005US20050054700 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
03/10/2005US20050054698 4-(4Methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3)
03/10/2005US20050054696 Indole compounds and medicinal use thereof
03/10/2005US20050054695 Treating neurological disorders using selective antagonists of persistent sodium current
03/10/2005US20050054691 drug mixtures comprising amides, aryl sulphonamides, aryl ureas, and alpha , beta-diketones, used as preferential human intestinal and insect enzyme hydrolase inhibitors; side effect reduction; treating effects of drug overdose
03/10/2005US20050054689 prostaglandin derivatives such as (Z)-7-((1R,2S,3R)-2-Butylcarbamoyloxymethyl-3-hydroxy-5-oxo-cyclopentyl)-hept-5-enoic acid methyl ester, administering to mammals for treatment of ocular hypertension; hypotensive agents
03/10/2005US20050054688 such as 3-[(dimethylamino)methyl]-4-[4-(methylsulfanyl)phenoxy]benzenesulfonamide for prevention of premature female orgasm; sexual disorders
03/10/2005US20050054687 Treatment of diabetes with thiazolidinedione and sulphonylurea
03/10/2005US20050054685 Pharmaceutical composition
03/10/2005US20050054683 Microbiocides; bacteriocides; oxazolidinone compound
03/10/2005US20050054682 Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
03/10/2005US20050054680 Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides
03/10/2005US20050054676 Materials and methods for the treatment of depression
03/10/2005US20050054675 Interferon $g(g) production promoter
03/10/2005US20050054673 Combination of phenylcarboxylic acid amides with beta-adrenoreceptor blockers and their use for the treatment of atrial arrhythmias
03/10/2005US20050054672 Quinolinone derivatives
03/10/2005US20050054671 Derivatives of alpha-phenylthiocarboxylic and $g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to pparalpha activation
03/10/2005US20050054669 Process for the synthesis of zolpidem
03/10/2005US20050054668 Antagonists of MCP-1 function and methods of use thereof
03/10/2005US20050054667 Using a 3,7-diazobicyclo(3.3.1)nonane compound
03/10/2005US20050054665 Adjust gene expresion; induction of immunology response; leukemia; antcancer agents; vaccines
03/10/2005US20050054663 GSK-3 inhibitors
03/10/2005US20050054662 Quinazoline derivatives as antitumor agents
03/10/2005US20050054661 Irritable bowel disorders; anxiolytic agents; antidepressants
03/10/2005US20050054659 Pyrazine modulators of cannabinoid receptors
03/10/2005US20050054658 4-Cycloalkylaminopyrazolo pyrimidine NMDA/NR2B antagonists
03/10/2005US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders
03/10/2005US20050054653 Pteridine derivatives, method of producing them and their application
03/10/2005US20050054652 Methods of treating metabolic syndrome using dopamine receptor agonists
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054650 Suppression tumor growth
03/10/2005US20050054647 New pharmaceutical combination
03/10/2005US20050054646 Compositions of a cyclooxygenase-2 selective inhibitor and an antioxidant agent for the treatment of central nervous system disorders
03/10/2005US20050054645 Aids therapy; side effect reduction
03/10/2005US20050054644 Hydrolytically-resistant boron-containing therapeutics and methods of use
03/10/2005US20050054641 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
03/10/2005US20050054639 Viricide against human t-cell leukemia/lymphoma virus infections
03/10/2005US20050054638 Anticancer agents
03/10/2005US20050054637 Prophylaxis, therapy cardiovascular disorders
03/10/2005US20050054635 Therapy , prevention of obsessive-complusive disorders; antidepressants; anxiety; schizophrenia; eating disorders; obesity; antiepileptic agents central nervous system disorders; sleep disorders
03/10/2005US20050054634 Azepinoindole derivatives as pharmaceutical agents
03/10/2005US20050054633 Malonamide derivatives
03/10/2005US20050054632 Naphthyl compounds, intermediates, compositions, and methods of use
03/10/2005US20050054631 Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
03/10/2005US20050054630 Fused bicyclic carboxamide derivatives and methods of their use
03/10/2005US20050054629 Antiproliferative agents; anticancer agents; restenosis
03/10/2005US20050054625 Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors
03/10/2005US20050054624 Administering steroid9such as estrogen) containing hydrophobic substitution such as adamamtane ring; Alzheimer's, Parkinson's, Huntington's disease; multiple sclerosis; amyotropic lateral sclerosis; stroke; antiischemic agents
03/10/2005US20050054623 Transdermal supplying testosterone gel
03/10/2005US20050054622 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound
03/10/2005US20050054621 Fractionation of phytosterol esters in oil
03/10/2005US20050054620 Antiproliferative agents; synergistic mixture with anticancer agents
03/10/2005US20050054619 Suppression tumor growth
03/10/2005US20050054618 Hypotensive agents; antiischemic agents; antiarrhythmia agents
03/10/2005US20050054617 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
03/10/2005US20050054616 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
03/10/2005US20050054615 Calmodulin independent activation of nitric oxide synthase
03/10/2005US20050054614 Methods of inhibiting leukocyte accumulation
03/10/2005US20050054612 In situ supplying to cells; adjust hydrophobic of drugs; drug delivery
03/10/2005US20050054611 Composition and method for use in intestinal cleansing procedures
03/10/2005US20050054609 Use of polysaccharide derivatives as anti-infective substances
03/10/2005US20050054607 Reaction product of drug, spacer and vitamin b12; drug delivery
03/10/2005US20050054606 Method for prevention of neuropsychiatric disorders
03/10/2005US20050054605 Partial or full A1 agonists - N6 heterocyclic 5' thio substituted adenosine derivatives
03/10/2005US20050054604 Labile linkage for compound delivery to a cell
03/10/2005US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders
03/10/2005US20050054601 Modified polynucleotides with phosphorothiolate linkage; animal growth regulators; immunomoderators; immunotherapy ; autoimmune disease
03/10/2005US20050054600 Modified protein kinase a-specific oligonucleotides and methods of their use
03/10/2005US20050054594 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
03/10/2005US20050054592 Alzheimer's disease; Parkinson's disease; isolated nucleic acids
03/10/2005US20050054590 Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus
03/10/2005US20050054589 Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics
1 ... 4759 4760 4761 4762 4763 4764 4765 4766 4767 4768 4769 4770 4771 4772 4773 4774 4775 4776 4777 4778 4779 ... 7860